Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR.
- DOI
- 10.1002/ctm2.70140
- Published
- 2025 Jan
- Container
- Clinical and translational medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/ctm2.70140,
title = {Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR.},
author = {Lam PY and Omer N and Wong JKM and Tu C and Alim L and Rossi GR and Victorova M and Tompkins H and Lin CY and Mehdi AM and Choo A and Elliott MR and Coleborn E and Sun J and Mercer T and Vittorio O and Dobson LJ and McLellan AD and Brooks A and Tuong ZK and Cheetham SW and Nicholls W and Souza-Fonseca-Guimaraes F},
year = {2025},
journal = {Clinical and translational medicine},
doi = {10.1002/ctm2.70140},
url = {https://doi.org/10.1002/ctm2.70140}
}RIS
TY - JOUR TI - Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR. AU - Lam PY AU - Omer N AU - Wong JKM AU - Tu C AU - Alim L AU - Rossi GR AU - Victorova M AU - Tompkins H AU - Lin CY AU - Mehdi AM AU - Choo A AU - Elliott MR AU - Coleborn E AU - Sun J AU - Mercer T AU - Vittorio O AU - Dobson LJ AU - McLellan AD AU - Brooks A AU - Tuong ZK AU - Cheetham SW AU - Nicholls W AU - Souza-Fonseca-Guimaraes F PY - 2025 JO - Clinical and translational medicine DO - 10.1002/ctm2.70140 UR - https://doi.org/10.1002/ctm2.70140 ER -
APA
PY, L., N, O., JKM, W., C, T., L, A., GR, R., M, V., H, T., CY, L., AM, M., A, C., MR, E., E, C., J, S., T, M., O, V., LJ, D., AD, M., A, B., ZK, T., SW, C., W, N., & F, S. (2025). Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR.. Clinical and translational medicine. https://doi.org/10.1002/ctm2.70140
Source records
- pubmed · retrieved 2026-09-25T23:21:51.728Z